Interleukin-2 in outpatients with renal cell carcinoma: SCAPP1 trial

Cancer Biother Radiopharm. 1996 Oct;11(5):297-300. doi: 10.1089/cbr.1996.11.297.
No abstract available

Publication types

  • Clinical Trial
  • Clinical Trial, Phase II
  • Multicenter Study

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Interleukin-2 / therapeutic use*
  • Kidney Neoplasms / drug therapy*
  • Male
  • Middle Aged
  • Outpatients
  • Recombinant Proteins / therapeutic use

Substances

  • Interleukin-2
  • Recombinant Proteins